CandlesenseCandlesense
MREO•benzinga•

CORRECTION: Mereo BioPharma Q1 GAAP EPS $(0.02) Misses $(0.01) Estimate. Cash And Equivalents Of $62.5M

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 13, 2025 by benzinga

← Back to MREO News
    CORRECTION: Mereo BioPharma Q1 GAAP EPS $(0.02) Misses $(0.01) Estimate. Cash And Equivalents Of $62.5M | MREO Stock News | Candlesense